186 related articles for article (PubMed ID: 24698190)
1. Nordic databases to evaluate medications in pregnancy.
Kieler H
Therapie; 2014; 69(1):65-9. PubMed ID: 24698190
[TBL] [Abstract][Full Text] [Related]
2. The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review.
Wettermark B; Zoëga H; Furu K; Korhonen M; Hallas J; Nørgaard M; Almarsdottir A; Andersen M; Andersson Sundell K; Bergman U; Helin-Salmivaara A; Hoffmann M; Kieler H; Martikainen J; Mortensen M; Petzold M; Wallach-Kildemoes H; Wallin C; Sørensen H
Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):691-9. PubMed ID: 23703712
[TBL] [Abstract][Full Text] [Related]
3. The Nordic countries as a cohort for pharmacoepidemiological research.
Furu K; Wettermark B; Andersen M; Martikainen JE; Almarsdottir AB; Sørensen HT
Basic Clin Pharmacol Toxicol; 2010 Feb; 106(2):86-94. PubMed ID: 19961477
[TBL] [Abstract][Full Text] [Related]
4. Trends in opioid consumption in the Nordic countries 2002-2006.
Hamunen K; Paakkari P; Kalso E
Eur J Pain; 2009 Oct; 13(9):954-62. PubMed ID: 19091608
[TBL] [Abstract][Full Text] [Related]
5. Trends in cancer incidence in the Nordic countries. A collaborative study of the five Nordic Cancer Registries.
Hakulinen T; Andersen A; Malker B; Pukkala E; Schou G; Tulinius H
Acta Pathol Microbiol Immunol Scand Suppl; 1986; 288():1-151. PubMed ID: 3465196
[TBL] [Abstract][Full Text] [Related]
6. Poisonings in the Nordic countries in 2007: a 5-year epidemiological follow-up.
Andrew E; Tellerup M; Termälä AM; Jacobsen P; Gudjonsdottir GA
Clin Toxicol (Phila); 2012 Mar; 50(3):210-4. PubMed ID: 22372789
[TBL] [Abstract][Full Text] [Related]
7. [Adverse drug reaction reports in Iceland from 2013 to 2016. A comparison with other Nordic countries].
Jonsdottir SS; Olafsdottir SM; Gudmundsdottir H
Laeknabladid; 2017 Jul; 103(07-08):319-323. PubMed ID: 28816174
[TBL] [Abstract][Full Text] [Related]
8. Mortality and morbidity of poisonings in the Nordic countries in 2002.
Andrew E; Irestedt B; Hurri T; Jacobsen P; Gudjonsdottir G
Clin Toxicol (Phila); 2008 Apr; 46(4):310-3. PubMed ID: 18363126
[TBL] [Abstract][Full Text] [Related]
9. Fatal poisoning in drug addicts in the Nordic countries in 2007.
Simonsen KW; Normann PT; Ceder G; Vuori E; Thordardottir S; Thelander G; Hansen AC; Teige B; Rollmann D
Forensic Sci Int; 2011 Apr; 207(1-3):170-6. PubMed ID: 21036495
[TBL] [Abstract][Full Text] [Related]
10. Standardized incidence rates of total hip replacement for primary hip osteoarthritis in the 5 Nordic countries: similarities and differences.
Lohmander LS; Engesaeter LB; Herberts P; Ingvarsson T; Lucht U; Puolakka TJ
Acta Orthop; 2006 Oct; 77(5):733-40. PubMed ID: 17068703
[TBL] [Abstract][Full Text] [Related]
11. The Clinical Practice Research Datalink for drug safety in pregnancy research: an overview.
Charlton R; Snowball J; Sammon C; de Vries C
Therapie; 2014; 69(1):83-9. PubMed ID: 24698192
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy exposure registries: academic opportunities and industry responsibility.
Wyszynski DF
Birth Defects Res A Clin Mol Teratol; 2009 Jan; 85(1):93-101. PubMed ID: 19107953
[TBL] [Abstract][Full Text] [Related]
13. The potential of the European network of congenital anomaly registers (EUROCAT) for drug safety surveillance: a descriptive study.
Meijer WM; Cornel MC; Dolk H; de Walle HE; Armstrong NC; de Jong-van den Berg LT;
Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):675-82. PubMed ID: 16761260
[TBL] [Abstract][Full Text] [Related]
14. Praxis and guidelines for planned homebirths in the Nordic countries - an overview.
Lindgren H; Kjaergaard H; Olafsdottir OA; Blix E
Sex Reprod Healthc; 2014 Mar; 5(1):3-8. PubMed ID: 24472383
[TBL] [Abstract][Full Text] [Related]
15. Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers.
Pukkala E; Andersen A; Berglund G; Gislefoss R; Gudnason V; Hallmans G; Jellum E; Jousilahti P; Knekt P; Koskela P; Kyyrönen PP; Lenner P; Luostarinen T; Löve A; Ogmundsdóttir H; Stattin P; Tenkanen L; Tryggvadóttir L; Virtamo J; Wadell G; Widell A; Lehtinen M; Dillner J
Acta Oncol; 2007; 46(3):286-307. PubMed ID: 17450464
[TBL] [Abstract][Full Text] [Related]
16. Fatal poisoning in Nordic drug addicts in 2002.
Steentoft A; Teige B; Holmgren P; Vuori E; Kristinsson J; Hansen AC; Ceder G; Wethe G; Rollmann D
Forensic Sci Int; 2006 Jul; 160(2-3):148-56. PubMed ID: 16289615
[TBL] [Abstract][Full Text] [Related]
17. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries.
Kvåle R; Auvinen A; Adami HO; Klint A; Hernes E; Møller B; Pukkala E; Storm HH; Tryggvadottir L; Tretli S; Wahlqvist R; Weiderpass E; Bray F
J Natl Cancer Inst; 2007 Dec; 99(24):1881-7. PubMed ID: 18073376
[TBL] [Abstract][Full Text] [Related]
18. NORDCAN--a Nordic tool for cancer information, planning, quality control and research.
Engholm G; Ferlay J; Christensen N; Bray F; Gjerstorff ML; Klint A; Køtlum JE; Olafsdóttir E; Pukkala E; Storm HH
Acta Oncol; 2010 Jun; 49(5):725-36. PubMed ID: 20491528
[TBL] [Abstract][Full Text] [Related]
19. Linking a pharmaceutical claims database with a birth defects registry to investigate birth defect rates of suspected teratogens.
Colvin L; Slack-Smith L; Stanley FJ; Bower C
Pharmacoepidemiol Drug Saf; 2010 Nov; 19(11):1137-50. PubMed ID: 20602344
[TBL] [Abstract][Full Text] [Related]
20. Postmenopausal hormone drugs and breast and colon cancer: Nordic countries 1995-2005.
Hemminki E; Kyyrönen P; Pukkala E
Maturitas; 2008 Dec; 61(4):299-304. PubMed ID: 18996655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
